114 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
28 May 24
Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
7:09am
, strategy, goals and anticipated milestones, including its ongoing and planned research activities, ability to conduct ongoing and planned clinical trials
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
2 May 24
Agios Reports Business Highlights and First Quarter 2024 Financial Results
7:01am
of its drug development, including PYRUKYND®, AG-946 and AG-181, its PAH stabilizer; Agios’ strategic vision and goals, including its key milestones … of pandemics or other public health emergencies to Agios’ business, operations, strategy, goals and anticipated milestones, including its ongoing
8-K
EX-99.1
j0cpomzwvm99uojk
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
8-K
EX-99.1
iux55ew
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.2
4ohg6l
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.1
i5vk tiuy
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
uxb8b
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
S-8
EX-99.1
q6w9fwvmm5uh3 tp1eut
13 Jun 23
Registration of securities for employees
4:13pm
8-K
EX-99.1
6t38kysloeebgnafsa4
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
c94o4vk oovw
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
ynu8sepo 0t58rqa8
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am